| Popis: |
Chapters 2– 4 of this book describe in details the mechanisms of localization for tumor-seeking agents. In this chapter we will consider only the most important radiopharmaceuticals currently used as tumor-seeking agents in clinical practice, and we will briefly summarize the PET modalities of PET imaging in oncology. We will also briefly discuss the main features of PET imaging as compared to conventional morphologic imaging (CT and MRI), in terms of biological meaning of the diagnostic information. Finally, a series of teaching cases will illustrate how PET-based imaging is currently employed for each type of cancer in the scenario of the most common clinical applications, e.g., staging, restaging, evaluation of response to therapy, and others. |
